Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 03, 2026 09:34 ET | Source: Research and Markets

Antibody-drug Conjugates (ADCs) in Oncology Market Competitive Landscape Report 2026: Comprehensive Insights About 200+ Companies and 220+ Drugs by Product Type, Stage, and Route of Administration

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Antibody-drug Conjugates (ADCs) in Oncology - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering.This report...
March 03, 2026 06:38 ET | Source: Research and Markets

ADC Cytotoxic Payloads and Warheads Industry Research Report 2026-2035 - Breakthrough Cancer Therapies and Next-Generation ADC Innovations Accelerate Market Expansion

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "ADC Cytotoxic Payloads and Warheads Market (2nd Edition): Trends and Forecast Til 2035 - Distribution Type of Product, Type of Payload, Sub-Category...
March 02, 2026 16:05 ET | Source: James River Group Holdings, Inc.

James River Announces Fourth Quarter 2025 Results

CHAPEL HILL, N.C., March 02, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the fourth quarter...
March 02, 2026 08:00 ET | Source: Artios Pharma

Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary Endpoint in Platinum-Resistant Ovarian Cancer

Low dose alnodesertib plus gemcitabine met the primary endpoint of progression-free survival (PFS) versus gemcitabine alone in patients with HGSOC
March 02, 2026 07:30 ET | Source: BioAtla, Inc.

BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets

SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic...
February 28, 2026 03:03 ET | Source: CUKTECH Technology Co., Ltd.

Bank Kuasa CUKTECH 25SE Melancarkan Debut Mantap di Malaysia, Mewujudkan Penanda Aras Baharu untuk Pengecasan Pantas Berkapasiti Tinggi

KUALA LUMPUR, Malaysia, Feb. 28, 2026 (GLOBE NEWSWIRE) -- CUKTECH, sebuah syarikat inovatif terkemuka dalam penyelesaian pengecasan pintar, hari ini mengumumkan pelancaran rasmi Bank Kuasa CUKTECH...
February 28, 2026 03:03 ET | Source: CUKTECH Technology Co., Ltd.

CUKTECH 25SE Power Bank Makes Its Powerful Debut in Malaysia, Setting a New Benchmark for High-Capacity Fast Charging

KUALA LUMPUR, Malaysia, Feb. 28, 2026 (GLOBE NEWSWIRE) -- CUKTECH, a leading innovator in intelligent charging solutions, today announced the official launch of its highly anticipated CUKTECH 25SE...
February 27, 2026 08:00 ET | Source: ALX Oncology

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

ALX Oncology Q4 and EOY 2025 earnings press release
February 26, 2026 09:10 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel...
February 26, 2026 07:30 ET | Source: Crescent Biopharma, Inc.

Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Established partnership with Kelun-Biotech expanding pipeline and accelerating combination strategy with CR-001, PD-1 x VEGF bispecific antibody, and multiple ADCs ASCEND Phase 1/2 global clinical...